![Next in Health artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts114/v4/0d/97/bb/0d97bba6-caf2-7e29-7e25-87565578020a/mza_12259312276345550761.jpg/100x100bb.jpg)
The year in Deals: Preparing for 2024
Next in Health
English - December 22, 2023 13:00 - 26 minutes - 18.5 MB - ★★★★★ - 25 ratingsHealth & Fitness healthcare health care health policy health regulations healthcare providers healthcare payors life sciences healthcare economy health economy patient care Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Next Episode: Reinventing for returns: what's next in pharma?
Tune in to hear PwC Deals leaders discuss preparing for deals in 2024, exploring the current state of the deals market and sharing valuable insights from their newly released 2024 deals outlook. Key topics include:
Fundamental changes and strategy trends for 2024 and how it’s shaping the health services and pharma landscapesThe role of the regulators and their impact on dealsBusiness model reinvention and the use of new technology to acquire better data and how it’s shaping the deals environment for 2024What’s on the horizon: Key success factors for good deal making in 2024Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.